W1 (Pyridostigmine Bromide Extended-Release 180 mg)
Pill with imprint W1 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Global Pharmaceuticals, Division of Impax Laboratories Inc..
Pyridostigmine is used in the treatment of myasthenia gravis; dysautonomia; nerve agent pretreatment; reversal of nondepolarizing muscle relaxants and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W1
Pyridostigmine Bromide Extended-Release
- Imprint:
- W1
- Strength:
- 180 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinergic muscle stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Global Pharmaceuticals, Division of Impax Laboratories Inc.
- National Drug Code (NDC):
- 00115-1404
More about pyridostigmine
- Pyridostigmine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 29 Reviews
- Drug class: cholinergic muscle stimulants
Consumer resources
- Pyridostigmine
- Pyridostigmine Extended-Release Tablets
- Pyridostigmine Tablets
- Pyridostigmine Injection
- Pyridostigmine Syrup
Other brands: Mestinon, Mestinon Timespan, Regonol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
